Serum Serine as a Metabolic Marker of Optic Neuropathy in Patients with Type 2 Diabetes Mellitus After Vitreoretinal Surgeries

Oleksii Ivashyn, Volodymyr Gryshchuk, Vita Ivashyna, Maryna Miasnykova, Heorhii Yurlov, Svitlana Stepanenko, Dmytro Zhaboiedov

Open source

DOI
10.3390/metabo16090622
Published
2026-08-28
Container
Metabolites
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo16090622,
  title = {Serum Serine as a Metabolic Marker of Optic Neuropathy in Patients with Type 2 Diabetes Mellitus After Vitreoretinal Surgeries},
  author = {Oleksii Ivashyn and Volodymyr Gryshchuk and Vita Ivashyna and Maryna Miasnykova and Heorhii Yurlov and Svitlana Stepanenko and Dmytro Zhaboiedov},
  year = {2026},
  journal = {Metabolites},
  doi = {10.3390/metabo16090622},
  url = {https://doi.org/10.3390/metabo16090622}
}

RIS

TY  - JOUR
TI  - Serum Serine as a Metabolic Marker of Optic Neuropathy in Patients with Type 2 Diabetes Mellitus After Vitreoretinal Surgeries
AU  - Oleksii Ivashyn
AU  - Volodymyr Gryshchuk
AU  - Vita Ivashyna
AU  - Maryna Miasnykova
AU  - Heorhii Yurlov
AU  - Svitlana Stepanenko
AU  - Dmytro Zhaboiedov
PY  - 2026
JO  - Metabolites
DO  - 10.3390/metabo16090622
UR  - https://doi.org/10.3390/metabo16090622
ER  - 

APA

Ivashyn, O., Gryshchuk, V., Ivashyna, V., Miasnykova, M., Yurlov, H., Stepanenko, S., & Zhaboiedov, D. (2026). Serum Serine as a Metabolic Marker of Optic Neuropathy in Patients with Type 2 Diabetes Mellitus After Vitreoretinal Surgeries. Metabolites. https://doi.org/10.3390/metabo16090622

Source records